Director receives 50,000 options at $0.94 at MIRA PHARMACEUTICALS, INC. (MIRA)
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
MIRA PHARMACEUTICALS, INC. director Matthew Paul Del Giudice reported receiving a grant of stock options. He was awarded 50,000 stock options to buy common stock at an exercise price of $0.94 per share, expiring on June 12, 2036.
The options were granted under the company’s 2022 Omnibus Incentive Plan. According to the vesting schedule, 50% of the options vest six months after the June 12, 2026 grant date, and the remaining half vests on the one-year anniversary of that date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Del Giudice Matthew Paul
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (right to buy) | 50,000 | $0.00 | -- |
Holdings After Transaction:
Stock Options (right to buy) — 50,000 shares (Direct, null)
Footnotes (1)
- The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026. The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date. Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each.
Key Figures
Stock options granted: 50,000 options
Exercise price: $0.94 per share
Options expiration: June 12, 2036
+4 more
7 metrics
Stock options granted
50,000 options
Grant to director on June 12, 2026
Exercise price
$0.94 per share
Equals closing price on June 12, 2026
Options expiration
June 12, 2036
Expiration date of granted stock options
Underlying shares
50,000 common shares
Shares issuable upon exercise of options
Post-transaction derivative holdings
50,000 options
Total options held after grant
Initial vesting
50% after six months
First tranche vesting from June 12, 2026 grant
Final vesting
50% after one year
Remaining tranche vests one year after grant date
Key Terms
Stock Options (right to buy), exercise price, 2022 Omnibus Incentive Plan, vest, +1 more
5 terms
Stock Options (right to buy) financial
"security_title: Stock Options (right to buy)"
exercise price financial
"at an exercise price of $0.94 each"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
2022 Omnibus Incentive Plan financial
"pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated"
vest financial
"50% of the options vest on the six-month anniversary of the grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"expiration_date: 2036-06-12T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did MIRA (MIRA) report for Matthew Paul Del Giudice?
MIRA director Matthew Paul Del Giudice reported receiving 50,000 stock options as compensation. These options allow him to buy common stock at a $0.94 exercise price and were granted under the company’s 2022 Omnibus Incentive Plan with time-based vesting.
How many stock options were granted to the MIRA director and at what price?
He was granted 50,000 stock options with an exercise price of $0.94 per share. This price equals the closing price of MIRA’s common stock on June 12, 2026, according to the footnotes accompanying the Form 4 filing.
What is the vesting schedule for the 50,000 MIRA stock options?
The 50,000 options vest in two equal blocks over 12 months. Half vests on the six-month anniversary of the June 12, 2026 grant date, and the remaining half vests on the one-year anniversary, subject to the terms of the 2022 Omnibus Incentive Plan.
When do Matthew Paul Del Giudice’s MIRA stock options expire?
The granted stock options expire on June 12, 2036. This gives the director a 10-year window from the grant date to exercise vested options at the $0.94 per share exercise price, in accordance with the plan terms described in the Form 4.
How many derivative securities does the MIRA director hold after this Form 4 transaction?
After this transaction, the director holds 50,000 stock options according to the Form 4. These options are derivative securities linked to an equivalent number of MIRA common shares, subject to vesting and exercisable at a $0.94 per share exercise price.